Treace Medical Concepts, Inc.
TMCI
$7.47
-$0.23-2.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.39M | 52.57M | 68.71M | 45.09M | 44.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.39M | 52.57M | 68.71M | 45.09M | 44.46M |
| Cost of Revenue | 9.64M | 10.68M | 13.23M | 8.95M | 8.78M |
| Gross Profit | 37.75M | 41.89M | 55.48M | 36.13M | 35.67M |
| SG&A Expenses | 49.23M | 51.91M | 50.47M | 46.30M | 51.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 64.36M | 68.15M | 68.86M | 60.22M | 65.84M |
| Operating Income | -16.97M | -15.58M | -151.00K | -15.13M | -21.38M |
| Income Before Tax | -17.40M | -15.92M | -501.00K | -15.36M | -21.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.40M | -15.92M | -501.00K | -15.36M | -21.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.40M | -15.92M | -501.00K | -15.36M | -21.21M |
| EBIT | -16.97M | -15.58M | -151.00K | -15.13M | -21.38M |
| EBITDA | -14.40M | -13.12M | 1.09M | -12.98M | -19.27M |
| EPS Basic | -0.28 | -0.25 | -0.01 | -0.25 | -0.34 |
| Normalized Basic EPS | -0.17 | -0.16 | 0.00 | -0.15 | -0.21 |
| EPS Diluted | -0.28 | -0.25 | -0.01 | -0.25 | -0.34 |
| Normalized Diluted EPS | -0.17 | -0.16 | 0.00 | -0.15 | -0.21 |
| Average Basic Shares Outstanding | 63.01M | 62.66M | 62.34M | 62.23M | 62.08M |
| Average Diluted Shares Outstanding | 63.01M | 62.66M | 62.34M | 62.23M | 62.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |